Notably, the mRNA expressions of RBM15 and IGF2BP1 were found to be increased in cetuximab-sensitive CRC tissues, besides, they were further increased in resistant CRC tissues (Fig. 7E). Here, IGF2BP1 is linked to colorectal carcinoma.